All In Biotech

Free tool

FAERS Monitor: Keppra Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022285 or its brand name (Keppra Xr, Levetiracetam). Reports on generic versions are filed under their own applications.

Reports

135,017

Serious

111,948

83% of reports

Hospitalization

49,995

Death reported

12,113

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure16,227
  • drug ineffective12,556
  • off label use9,747
  • fatigue5,664
  • somnolence4,247
  • epilepsy4,201
  • convulsion4,079
  • maternal exposure during pregnancy3,821
  • fall3,812
  • headache3,770
  • nausea3,654
  • dizziness3,638
  • drug interaction3,513
  • diarrhoea3,306
  • death3,286

Reports by year received

View as table
YearReports
2004515
2005758
2006908
20071,182
20081,356
20092,211
20102,463
20113,071
20124,029
20134,131
20144,698
20156,500
20168,419
20177,673
201810,372
201912,026
20209,949
202110,133
20228,974
20239,610
20249,964
20258,933
20267,138

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,919,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal16,22725.324.9327,276
epilepsySignal4,20124.723.982,345
convulsionSignal4,07911.911.537,869
maternal exposure during pregnancySignal3,8216.96.718,642
drug interactionSignal3,5133.53.46,194
somnolenceSignal4,2473.33.26,860
fall3,8121.81.71,343
off label use9,7471.71.73,180
drug ineffective12,5561.51.52,129
dizziness3,6381.11.161
fatigue5,6641.11.193
headache3,7700.90.917
diarrhoea3,3060.80.8176
nausea3,6540.70.7419
death3,2860.60.6955

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.